Investment decisions in medical technology carry asymmetric risk
Clinical evidence, regulatory pathways, manufacturing scale-up, and reimbursement are often poorly understood �" even when financials look attractive. Missed risks can destroy value post-investment.
Integrated technical and commercial due diligence
We deliver integrated technical and commercial due diligence tailored to medical devices, diagnostics, and digital health.
Our assessments cover technology, clinical validity, regulatory strategy, quality systems, manufacturing readiness, market access, and commercial scalability.
We translate complex technical findings into clear, decision-grade insights for investment committees.
True Risk Visibility
Clear understanding of technical, regulatory, and execution risk before capital is committed.
IC-Ready Insight
Complex diligence findings translated into concise, decision-grade conclusions.
Better Deal Structuring
Early identification of value drivers and red flags to inform valuation and milestones.Request a diligence scoping discussion
Ensure your next investment decision is backed by rigorous technical and commercial insight.
Not sure, it’s right for you? Browse our related resources and services below.
